End-of-day quote
Other stock markets
|
||
- USD | - |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Timothy Walbert
CEO | Chief Executive Officer | 57 | 31/05/08 |
Aaron Cox
DFI | Director of Finance/CFO | 41 | 31/03/16 |
Karin Rosen
CTO | Chief Tech/Sci/R&D Officer | 57 | 01/11/20 |
Vikram Karnani
CTO | Chief Tech/Sci/R&D Officer | 49 | 30/06/14 |
Chief Tech/Sci/R&D Officer | 66 | 30/09/16 | |
Jeffrey Sherman
CTO | Chief Tech/Sci/R&D Officer | 69 | 31/05/09 |
Keli Walbert
SAM | Sales & Marketing | - | 31/12/17 |
Comptroller/Controller/Auditor | 45 | 31/01/15 | |
David Caraher
SEC | Corporate Secretary | - | - |
Jane Gonnerman
HRO | Human Resources Officer | - | 30/09/21 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Timothy Walbert
CEO | Chief Executive Officer | 57 | 31/05/08 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 229,378,934 | 226,691,767 ( 98.83 %) | 384,366 ( 0.1676 %) | 98.83 % |
Company contact information
Horizon Therapeutics Plc
70 St. Stephen's Green
4, Dublin
+353 1 772 2100
http://www.horizontherapeutics.comGroup companies
Name | Category and Sector |
---|---|
Horizon Pharma Treasury Ltd.
|
Sector
1st Jan change | Capi. | |
---|---|---|
+31.47% | 588B | |
-3.42% | 364B | |
+18.02% | 326B | |
+4.27% | 285B | |
+15.21% | 239B | |
+10.13% | 210B | |
-7.16% | 200B | |
+8.12% | 167B | |
-1.42% | 161B |
- Stock Market
- Equities
- HZNP Stock
- Stock
- Company Horizon Pharma Inc